Draerofit 50/100 Capsule

Draerofit 50/100 Capsule is a prescription combination medicine that contains salmeterol 50 mcg and fluticasone propionate 100 mcg in each capsule. It belongs to the long-acting beta2-agonist (LABA) plus inhaled corticosteroid (ICS) class, and it is used for maintenance treatment of asthma. This strength is designed to help reduce airway inflammation and keep the airways open over time, not to treat a sudden asthma attack.

How it works: Salmeterol helps relax the muscles around the airways so breathing stays easier for longer, while fluticasone propionate reduces swelling and irritation inside the lungs. In capsule form, Draerofit 50/100 Capsule is taken regularly as a controller medicine so these effects build up and help prevent asthma symptoms.

Draerofit 50/100 Capsule is a higher-strength combination capsule, so it is typically chosen for patients whose asthma needs more controller support than lower-dose options can provide. Because it contains salmeterol and fluticasone propionate together, a doctor may prescribe this exact strength when symptom control is not enough on a lower dose or when stepping therapy up is appropriate.

• Maintenance treatment of asthma
• Prevention of wheezing and shortness of breath
• Long-term control of airway inflammation
• Reducing daytime and nighttime asthma symptoms
• Helping lower the risk of asthma flare-ups when used regularly

• Take Draerofit 50/100 Capsule exactly as prescribed and use it regularly, even when you feel well.
• Use the capsule only with the inhalation device prescribed for this product; swallow the capsule only if your doctor or pharmacist specifically tells you to.
• Do not take it to relieve a sudden asthma attack; keep your rescue inhaler available for quick relief.
• If you are using the inhalation device for the first time, ask a pharmacist to show you how to load and inhale from the capsule correctly.
• Rinse your mouth with water after each dose and spit it out to help lower the risk of oral thrush.
• Do not exceed the dose your doctor prescribes, and do not use extra capsules for symptoms unless your clinician tells you to.

Each Draerofit 50/100 Capsule provides salmeterol 50 mcg plus fluticasone propionate 100 mcg per capsule. It is usually taken twice daily as a maintenance dose, but your doctor decides the exact schedule based on your asthma control and past treatment. Do not take more than prescribed; this medicine is not for extra, as-needed use.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Salmeterol + Fluticasone Propionate may include:

• Throat irritation
• Hoarseness or voice changes
• Oral thrush (fungal infection in the mouth)
• Headache
• Cough or throat dryness
• Nervousness or tremor
• Palpitations or fast heartbeat

• Do not use Draerofit 50/100 Capsule for sudden asthma symptoms or an acute attack.
• Because this is a stronger controller dose, it should be used only under a doctor’s supervision and should not be increased on your own.
• Tell your doctor if you have heart disease, high blood pressure, arrhythmia, diabetes, thyroid disease, seizures, or low potassium.
• Use caution if you have a history of oral thrush, recurrent infections, or weakened immune function.
• Avoid stopping the medicine suddenly without medical advice, especially if your asthma has been hard to control.
• Tell your clinician if you are pregnant, breastfeeding, or need repeated rescue inhaler use.
• Alcohol is not a direct interaction, but breathing symptoms or dizziness should be monitored if you drink alcohol.

• Other LABA medicines or asthma inhalers containing salmeterol
• Strong CYP3A4 inhibitors such as ritonavir, cobicistat, ketoconazole, or itraconazole
• Beta-blockers such as propranolol or timolol
• Diuretics or medicines that can lower potassium
• MAO inhibitors or tricyclic antidepressants

Store Draerofit 50/100 Capsule in the original strip/box at room temperature, away from moisture and heat, and keep the capsules dry until use.